| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8228045 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 8 Pages |
Abstract
The delivery of SLDR is feasible in patients with recurrent gliomas and resulted in improved outcomes for patients who underwent re-resection. There were 2 long-term survivors (>48 months). This pilot study supports the notion that reduced dose rate influences the efficacy and tolerance of reirradiation in the treatment of recurrent gliomas.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Malika L. M.D., Selim Y. M.D., Wade M.D., Hendrikus M.D., Ph.D., Christopher J. M.D.,